Pioneer in Women's Blood Disorders Receives Lifetime Achievement Award from the Society of Maternal-Fetal Medicine
Charles E. Lockwood, MD, MHCM, senior vice-president for University of South Florida (USF) Health and Dean of the Morsani College of Medicine, has recently received the Society for Maternal-Fetal Medicine (SMFM) Lifetime Achievement Award for his impact and scientific contributions that have significantly improved healthcare for pregnant women.
The Society was established in 1977 to give MFM physicians and scientists a place to share knowledge, research, and clinical best practices in order to improve care for moms and babies. The Society’s focus is to lead the global advancement of women’s and children’s health through pregnancy care, research, advocacy, and education, as well as to improve maternal and child outcomes and raise the standards of prevention, diagnosis, and treatment of maternal and fetal disease through support for the clinical practice of maternal-fetal medicine, research, education/training, advocacy, and health policy leadership (smfm.org).
Dr. Lockwood is an internationally-renowned physician who focuses on the prevention of recurrent pregnancy loss, preterm delivery, and maternal thrombosis. A graduate of the University of Pennsylvania School of Medicine, he completed his residency in obstetrics and gynecology at Pennsylvania Hospital and fellowship training in maternal-fetal medicine at Yale-New Haven Hospital; he has a Master of Science degree in Health Care Management from Harvard School of Public Health.
Before helping to launch and practice in the USF’s Pregnancy Loss Prevention Center, Dr. Lockwood was the dean of the Ohio State University College of Medicine and vice president of Health Sciences. He is currently a member of the Institute of Medicine of the National Academies.
Please join us in our congratulations to Dr. Lockwood for receiving this prestigious award. To read more, click HERE.
Long-term colleague and friend, Dr. Michael Paidas writes:
Dr. Lockwood's impact on the healthcare of women across their life spectrum, as well as their families, is immeasurable and long-lasting. In particular, his specific contributions to the field of blood disorders range from basic science breakthroughs, describing the important role of Tissue Factor in common pregnancy complications, to authoring key guidelines which have helped clinicians manage our challenging patients with hematologic issues affecting adolescence, pregnancy, and menopause. Charly has trained a generation of clinicians and scientists who are indebted to him for his mentoring, support, and endless energy. Charly has been a leading advocate for blood disorders at the federal level, influencing our national healthcare agenda and striving to ensure that our patients have the care and resources their unique healthcare problems deserve.
From all of us who have had the good fortune of knowing Charly, appreciating his brilliance, wit and wisdom: Congratulations to Charly—Mentor, Colleague nonpareil and, most of all, Friend.
- Michael Paidas, MD, Professor of Obstetrics, Gynecology, and Reproductive Sciences, Yale University; Director of the Yale Women and Children's Center for Blood Disorders and Preeclampsia Advancement